GLPBio

Aloesin

Catalog No.: GC38398Purity:>98.00%
Aloesin is a potent and selective inhibitor of tyrosinase with IC50 value of 31.5μM.

Products are for research use only. Not for human use. We do not sell to patients.


Aloesin
Cas No.: 30861-27-9
10mM (in 1mL DMSO)In Stock
$4.00
1
1mgIn Stock
$15.00
1
5mgIn Stock
$39.00
1
10mgIn Stock
$62.00
1

Citations

No citations are currently available for this product. Below are selected publications citing GlpBio products.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Description

Aloesin is a potent and selective inhibitor of tyrosinase with IC50 value of 31.5μM [1]. Aloesin has direct inhibitory effects on melanogenesis and showed dose-dependent reductions in tyrosinase activity[2]. Aloesin has been widely used to inhibit excessive pigmentation caused by ultraviolet radiation[3].

In vitro, Aloesin treatment for 48 hours significantly inhibited the proliferation of SKOV3 cells, with an IC50 value of 5μM[4]. Without the presence of Wnt3a ligand, treatment with 20μM Aloesin for 12 hours can increase the protein level of active β-catenin in NIH/3T3 cells, and promote the expression of Wnt cascade genes[5]. Treatment with 20μM Aloesin for 24 hours significantly increased the levels of cyclin E, CDK2 and CDC25A in SK-HEP-1 cells[6].

In vivo, Aloesin treatment via oral administration at a dose of 40mg/kg/day for 7 consecutive days effectively reduced psoriasis area severity index (PASI) scores without any significant changes in the body weight of mice and ameliorated psoriatic lesions [7]. Administer Aloesin (200mg/kg) orally twice a week for 12 weeks significantly reduced obesity-related oxidative stress and hepatic steatosis in rats fed with a high-fat diet (HFD)[8].

References:
[1] Mikayoulou M, Mayr F, Temml V, et al. Anti-tyrosinase activity of South African Aloe species and isolated compounds plicataloside and aloesin[J]. Fitoterapia, 2021, 150: 104828.
[2] Wang Z, Li X, Yang Z, et al. Effects of aloesin on melanogenesis in pigmented skin equivalents[J]. International journal of cosmetic science, 2008, 30(2): 121-130.
[3] Choi S, Park Y I, Lee S K, et al. Aloesin inhibits hyperpigmentation induced by UV radiation[J]. Clinical and experimental dermatology, 2002, 27(6): 513-515.
[4] Zhang L, Lv R, Qu X, et al. Aloesin suppresses cell growth and metastasis in ovarian cancer SKOV3 cells through the inhibition of the MAPK signaling pathway[J]. Analytical Cellular Pathology, 2017, 2017(1): 8158254.
[5] Peng C, Zhang W J, Dai C, et al. Study of the aqueous extract of Aloe vera and its two active components on the Wnt/β-catenin and Notch signaling pathways in colorectal cancer cells[J]. Journal of ethnopharmacology, 2019, 243: 112092.
[6] Lee K Y, Park J H, Chung M H, et al. Aloesin up‐regulates cyclin E/CDK2 kinase activity via inducing the protein levels of cyclin E, CDK2, and CDC25A in SK‐HEP‐1 cells[J]. IUBMB Life, 1997, 41(2): 285-292.
[7] Alsahli T G, Alharbi K S, Alenezi S K, et al. Aloesin alleviates imiquimod-induced psoriasis in dermal layers through inhibition of interleukins and NF-κB signaling pathways[J]. Scientific Reports, 2025.
[8] Alamri S M, Al-Harbi L N, Alshammari G M, et al. Aloesin activates Nrf2 signaling to attenuate obesity-associated oxidative stress and hepatic steatosis in high-fat diet-fed rats[J]. Scientific Reports, 2025, 15(1): 34888.

Protocol

Cell experiment [1]:

Cell lines

SKOV3 cells

Preparation Method

SKOV3 cells were cultured in a medium supplemented with 10% fetal bovine serum (FBS) and 100U/ml penicillin/streptomycin. The cells were incubated in a humidified environment at 37°C with 5% CO2. SKOV3 cells were seeded at a density of 5×103 cells per well in a 96-well plate and cultured overnight. Then, the cells were treated with different concentrations (0, 2.5, 5, 10, 20, and 40μM) of Aloesin for 48 hours, and the cell viability after aloin treatment was analyzed.

Reaction Conditions

0, 2.5, 5, 10, 20, and 40μM; 48h

Applications

Aloesin treatment inhibited the growth of SKOV3 cells in a dose-dependent manner.
Animal experiment [2]:

Animal models

Wistar albino rats

Preparation Method

Wistar albino rats (120±15g) were placed in standard laboratory cages lined with suitable wood chips and maintained in a controlled environment with a temperature of (20-22°C) and humidity of (40-60%). A 12-hour light/12-hour dark daily cycle was maintained throughout the entire study period. The rats had free access to food and water. After one week of adapting to the environment, 24 adult rats were randomly divided into 3 groups (n=8 in each group): (1) Control group (standard diet+solvent); (2) Control group+Aloesin (200mg/kg); (3) HFD+Aloesin (200mg/kg), with the Aloesin administered orally twice a week for 12 weeks. Liver tissues of the rats were collected for analysis.

Dosage form

200mg/kg; twice a week for 12 weeks; p.o.

Applications

Aloesin reduced liver damage and mitigated the increase in liver enzymes in HFD-fed rats.

References:
[1] Zhang L, Lv R, Qu X, et al. Aloesin suppresses cell growth and metastasis in ovarian cancer SKOV3 cells through the inhibition of the MAPK signaling pathway[J]. Analytical Cellular Pathology, 2017, 2017(1): 8158254.
[2] Alamri S M, Al-Harbi L N, Alshammari G M, et al. Aloesin activates Nrf2 signaling to attenuate obesity-associated oxidative stress and hepatic steatosis in high-fat diet-fed rats[J]. Scientific Reports, 2025, 15(1): 34888.

Product Documents

Purity:>98.00%Appearance:A solid

Chemical Properties

CAS No.
30861-27-9
SMILES
OC1=CC(C)=C(C(C=C(CC(C)=O)O2)=O)C2=C1[C@@H]3O[C@@H]([C@@H](O)[C@H](O)[C@H]3O)CO
Molecular Formula
C19H22O9
Molecular Weight
394.37
Solubility
DMSO: 270 mg/mL (684.64 mM)
Storage
4°C, protect from light
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for Aloesin

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%